London, United Kingdom
May 13, 2026

Our oversubscribed Series A is complete with a total of $10.3 million raised 🤩

We are on a mission to become the world's leading plant disease resistance company, developing both in-house traits, and collaborating with leading seed companies to protect crops 🌱💪

The final close was oversubscribed and led by Corteva Agriscience, alongside Calculus Capital, Pymwymic, UK Innovation & Science Seed Fund [UKI2S] (Future Planet Capital), SynBioVen and AgFunder. As evidenced by our recent get-together in London, we are excited to be working closely with such an experienced and supportive group!

👏 With this financing round complete, we've already started ramping up production of our in-house crop protection traits and taking our computational protein-protein interaction screening tool, FloraFold® AI, to the next level.

🫢 Resurrect Bio is now also open to collaborations with FoodCos, seed companies and breeders. We recently announced our partnership on Corn with Corteva Agriscience and we'll be announcing another partnership very soon 🎉

Get in touch if you want to learn more.

Thank you to all our investors, advisors, mentors, partners and, of course, our team throughout this process.

Now, let's get back to the science 🤓🧬 👩‍🔬🧫!

Website: https://www.resurrect.bio/

Published: May 14, 2026